Pramipexole Extended Release: In Parkinson's Disease

Author： Chwieduk Claudine M.   Curran Monique P.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.4, 2010-04, pp. : 327-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease

By Perez Lloret Santiago   Rascol Olivier  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2221-2230

Informa Healthcare

Access to resources Recommend Favorite

Role of Pramipexole in the Management of Parkinson's Disease

By Antonini Angelo   Barone Paolo  

CNS Drugs, Vol. 24, Iss. 10, 2010-10 ,pp. : 829-841

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pramipexole in Parkinson's Disease in the US

By Hoerger T.J.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 541-557

Adis International

Access to resources Recommend Favorite

Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness

By Noyes Katia   Dick Andrew W.   Holloway Robert G.   The Parkinson Study Group  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1257-1270

Adis International

Access to resources Recommend Favorite

Pramipexole: A Review of its Use in the Management of Early and Advanced Parkinson's Disease

By Dooley M.   Markham A.  

Drugs & Aging, Vol. 12, Iss. 6, 1998-06 ,pp. : 495-514

Adis International

Access to resources Recommend Favorite